William Scully reports 10.27% stake in PROTHENA
Prothena Corp Public Ltd: William P. Scully filed an amended Schedule 13G/A reporting beneficial ownership of 5,378,846 Ordinary Shares, representing approximately 10.27% of the company's 52,353,237 shares outstanding as of April 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Prothena Corp Public Ltd: William P. Scully filed an amended Schedule 13G/A reporting beneficial ownership of 5,378,846 Ordinary Shares, representing approximately 10.27% of the company's 52,353,237 shares outstanding as of April 30, 2026. The filing breaks ownership into positions with 793,000 shares of sole voting/dispositive power and 4,585,846 shares of shared voting/dispositive power.
Insights
Holder reports a significant ~10% position with mixed voting control.
The filing states the reporting person may be deemed beneficial owner of 5,378,846 Ordinary Shares, or 10.27% of outstanding shares as of April 30, 2026. Ownership aggregates direct IRA holdings, manager-controlled LLC interests, and trust-related positions.
Control features are mixed: 793,000 shares are held with sole voting/dispositive power while 4,585,846 are shared. Subsequent disclosures may clarify voting arrangements or transfers; current filings anchor the position to the cited share counts and ownership mechanisms.
Schedule 13G/A updates beneficial ownership and cites specific trust/IRA holdings.
The filing itemizes constituent holdings including a manager-controlled LLC, multiple IRAs, and grantor retained annuity trusts, and notes shared powers arising from retained rights to substitute assets. The filing is signed by an attorney-in-fact on 05/11/2026.
Regulatory readers should note the filing format (amendment) and the explicit outstanding-share anchor: 52,353,237 shares as of April 30, 2026. No transaction timing or changes in percentage ownership beyond the amendment language are provided.
Key Figures
Key Terms
beneficial owner regulatory
grantor retained annuity trusts financial
dispositive power regulatory
investment management agreement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does William P. Scully report in PROTHENA (PRTA)?
What voting and dispositive powers does the filing show for Scully?
Which account types and entities contribute to the reported holdings?
Who signed the amended Schedule 13G/A for this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.